COVID-19 Vaccination in Children: Lessons Learned from Human Papillomavirus Vaccination
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Nearly 7.4 million children have tested positive for COVID-19 since the pandemic began.1 As Omicron variant cases explode nationwide, this raises future questions for schools managing the ever evolving COVID-19 landscape. Vaccination can mitigate potential long-term effects of COVID-19 among infected children.2 However, only 62% of children ages 12-17 years are fully vaccinated.2 Adolescent vaccines, such as human papillomavirus (HPV) vaccines, provides lessons learned for COVID-19 vaccination in children. This paper describes similarities and differences in HPV and COVID-19 vaccines and discusses implications of successful strategies that increased adolescent HPV vaccination for ongoing efforts to promote COVID-19 vaccination in children.
Journal of Adolescent Health , commentaire en libre accès, 2021